PDCD1 and gastric cancer: However, the efficacy of combining ADCs with PD‐1/PD‐L1 inhibitors still requires validation through larger clinical studies, with ongoing trials evaluating ADCs targeting HER2, claudin18.2, or Trop2 in combination with PD‐1 inhibitors for GC treatment.